RISK FACTORS FOR COGNITIVE IMPAIRMENT AND NIGHT SLEEP DISORDERS IN PATIENTS WITH PARKINSON’S DISEASE


Cite item

Full Text

Abstract

The features of cognitive impairment and night sleep disorders in patients with Parkinson’s disease, depending on gender, clinical form, time of onset, disease duration and degree of motor impairment have been studied. It was found that cognitive impairment and night sleep disorders become not only stronger in the course of the disease, but are closely related to each other. The degree of movement disorders linked with sleep disorders can be seen in men only. In addition, we found that cognitive deficits, as well as sleep disturbances, do not depend on sex, clinical forms of PD and the age of onset of the disease.

About the authors

Gulnara N Akhmadeeva

1) G.G. Kuvatov Rebublic clinical hospital; 2) Institute of Biochemistry and Genetics of Ufa scientific centre RAS

Email: nevrolog.ufa@gmail.com
1) 450005, Dostoevsky street, 132; 2) 450054, Ufa, Prospect Oktjabrja, 71

Gulnaz N Tayupova

G.G. Kuvatov Rebublic clinical hospital

Ufa, 450005, Dostoevsky street, 132

Rim V Magzhanov

Bashkir State Medical University

кафедра неврологии с курсами нейрохирургии и медицинской генетики 450000, Ufa, Lenin street, 3

Azamat R Bajtimerov

Bashkir State Medical University

кафедра неврологии с курсами нейрохирургии и медицинской генетики 450000, Ufa, Lenin street, 3

Irina M Hidijatova

Institute of Biochemistry and Genetics of Ufa scientific centre RAS

450054, Ufa, Prospect Oktjabrja, 71

References

  1. Байтимеров А.Р. Эпидемиологическое и клинико-генетическое изучение болезни Паркинсона в Республике Башкортостан: Автореф. дисс.. канд. мед. наук. Уфа, 2007.
  2. Вейн А.М., Левин Я.И. Нарушение сна и бодрствования. В кн.: Болезни нервной системы. М: Медицина, 2001. С. 391-413.
  3. Глозман Ж.М., Артемьев Д.В., Дамулин И.В., Ковязина М.С. Возрастные особенности нейропсихологических расстройств при болезни Паркинсона // Вестник Московского университета. Серия 14. Психология. 1994. № 3. С. 25-36.
  4. Залялова З.А., Яковлева Л.А., Богданов Э.И. Немоторные проявления болезни Паркинсона: методическое пособие для постдипломного образования. Казань: КГМУ, 2009. 33 с.
  5. Крыжановский Г.Н., Карабань И.Н., Магаева С.В. и др. В кн.: Болезнь Паркинсона. М: Медицина, 2002. С. 55-56.
  6. Кулуа Т. Ночные симптомы болезни Паркинсона. Болезнь Паркинсона и расстройства движений. Руководство для врачей. М., 2008. С. 100-103.
  7. Левин О.С., Батукаева Л.А., Смоленцева И.Г. Диагностика и лечение деменции при болезни Паркинсона // Журнал неврологии и психиатрии им. Корсакова. 2008. № 6. С. 85-91.
  8. Нодель М.Р. Нарушения сна при болезни Паркинсона. Болезнь Паркинсона и расстройства движений. Руководство для врачей. М., 2008. С. 277-278.
  9. Яблонская А.Ю., Федорова Н.Ф., Бельгушева М.Э. Влияние сульфата амантадина на когнитивные нарушения у пациентов с болезнью Паркинсона // Журнал неврологии и психиатрии им. С.С. Корсакова. 2010. Т. 110, № 7. С. 24-30.
  10. Aarsland D., Bronnick K., Williams-Gray C.H. et al. Mild cognitive impairment in Parkinson’s disease: A multicentre pooled analysis // Neurology. 2010. Vol. 75. P. 1062-1069.
  11. Arnulf I., Konofal E., Merino-Andreu M., Mesnage V. et al. Parkinson’s disease and sleepiness: an integral part of PD // Neurology. 2002. Vol. 58 (7). P. 1019-1024.
  12. Beck A.T., Steer R.A., Ball R., Ranieri W.J. Comparison of Beck Depression Inventories -IA and -II in psychiatric outpatients // Pers Assess. 1996. Vol. 67 (3). P. 588-597.
  13. Chung S., Bohnen N.I., Albin R.L. et al. Insomnia and Sleepiness in Parkinson Disease: Associations with Symptoms and Comorbidities // J. Clin. Sleep Med. 2013. Vol. 9(11). P. 1131-1137.
  14. Comella C. Sleep disorders in Parkinsons disease: an overview // Mov Dis (Suppl.17). 2007. Vol. 22. P. 367-373.
  15. Emre M., Aarsland D., Brown R., et al. Clinical diagnostic criteria for dementia associated with Parkinson disease // Mov Dis. 2007. Vol. 22. P. 1689-1707.
  16. Factor S.A., McAlarney T., Sanchez-Ramos J.R., Wiener W.J. Sleep disorders and sleep effect in Parkinson’s disease // Movement Dis. 1990. Vol. 5. P. 280-285.
  17. Fahn S., Elton R.L. UPDRS Development Committee. Unified Parkinson’s Disease Rating Scale // Recent Developments in Parkinson’s Disease [eds. S. Fahn, C.D. Marsden, D. Calne, M. Goldstein]. Macmillan Health Care Information; Florham Park N.J. 1987, P. 153-163.
  18. Folstein M.F., Folstein S.E., McHugh P.R. “Mini-Mental State”: a practical method for grading the cognitive state of patients for the clinician // J. Psychiatr. Res. 1975. Vol. 12. P. 196-198.
  19. Friedman J.H., Millman R.P. Sleep disturbances and Parkinson’s disease // CNS Spectr. 2008. Vol. 13 (3). P. 12-20.
  20. Ganga G., Alty J.E., Clissold B.G. et al. Longitudinal study of levodopa in Parkinson’s disease: effects of the advanced disease phase // Mov Disord. 2013. Apr. Vol. 28(4). P. 476-481.
  21. Gomez-Esteban J.C., Tijero B., Somme J. et al. Impact of psychiatric symptoms and sleep disorders on the quality of life of patients with Parkinson’s disease // J. Neurol. 2011. Vol. 258. P. 494-499.
  22. Hoehn M.M., Yahr M.D. Parkinsonism: onset, progression, and mortality // Neurology. 1967. Vol. 17. P. 427-442.
  23. Hughes A.J., Daniel S.E., Blankson S., Lees A.J. A clinicopathological study of 100 cases of Parkinson’s disease // Arch. Neurol. 1992. Vol. 50. P. 140-148.
  24. Lees A.J., Smith E. Cognitive deficits in the early stages of Parkinson’s disease // Brain. 1983. Jun. 106 (Pt 2). P. 257-270.
  25. Levin B.E., Tomer R., Rey G.J. Cognitive impairments in Parkinson’s disease // Neurol. Clin. 1992. May. Vol. 10(2). P. 471-485.
  26. Lindvall O., Rehncrona S., Brundin P. et al. Human fetal dopamine neurons grafted into the striatum in two patients with severe Parkinson’s disease. A detailed account of methodology and a 6-month follow-up // Arch. Neurol. 1989. Vol. 46 (6). P. 615-631.
  27. Sollinger A.B., Goldstein F.C., Lah J.J. et al. Mild cognitive impairment in Parkinson’s disease: subtypes and motor characteristics // Parkinsonism Relat Disord. 2010. Vol. 16(3). P. 177-180.
  28. Spielberger C.D., Gorsuch R.L. Manual for the State-trait anxiety inventory (form Y) (“self-evaluation questionnaire”). Palo Alto, CA : Consulting Psychologists Press, 1983.
  29. Starkstein S.E., Mayberg H.S., Preziosi T.J. Reliability, validity, and clinical correlates of apathy in Parkinson’s disease // J. Neuropsychiatry Clin. Neurosci. 1992. Vol. 4. P. 134-139.
  30. Swick TJ. Parkinson’s disease and sleep/wake disturbances. Parkinsons Dis. 2012:205471.
  31. Tandberg E., Larsen J.P., Karlsen K. Excessive daytime sleepiness and sleep benefit in Parkinson’s disease: a community-based study // Mov Dis. 1999. Vol. 14 (6). P. 922-926.
  32. Verbaan D., van Rooden S.M., Visser M. Nighttime sleep problems and daytime sleepiness in Parkinson’s disease // Mov Disord. 2008. Vol. 23. P. 35-41.
  33. Williams-Gray C.H., Evans J.R., Goris A. et al. The distinct cognitive syndromes of Parkinson’s disease: 5 year follow-up of the CamPaIGN cohort // Brain. 2009. Vol. 132. P. 2958-2969.
  34. Zhou H., Shen C., Chen J. et al. Tremor and clinical fluctuation are related to sleep disorders in Chinese patients with Parkinson’s disease // Transl Neurodegener. 2014. Vol. 3. P. 21.

Copyright (c) 2015 Akhmadeeva G.N., Tayupova G.N., Magzhanov R.V., Bajtimerov A.R., Hidijatova I.M.

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies